cyproviron Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C
  • InChIKey: UWFYSQMTEOIJJG-FDTZYFLXSA-N
  • Mol. Mass: 416.95
  • ALogP: 4.61
  • ChEMBL Molecules:
    cyproterone acetate  
    cyproterone  
More Chemistry

Pharmacology

Drug Pricing (per unit)

Australia

$0.5551 - $0.8868
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

androcur | androcur 10 | cyprostat | cyproterone | cyproterone 17-o-acetate | cyproterone acetate | cyproterone acetate - ethinyl estradiol | cyproterone acetate, ethinyl estradiol drug combination | cyproviron | diane | diane-35 | diane-35 diario | sh-714 | shb 209 ae

Organizations (58)

Research & Development (58)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (18)

Approved Indications (1)


 

Prostatic Neoplasms

Experimental Indications - Clinical Trial Phases 1-4 (18)


 

Acne Vulgaris (Phase 3)

Amenorrhea (Phase 4)

Dysmenorrhea (Phase 4)

Endometrial Hyperplasia (Phase 2/Phase 3)

Endometrial Neoplasms (Phase 2/Phase 3)

Endometriosis (Phase 3)

Gender Dysphoria (Phase 4)

Hot Flashes (Phase 3)

Hyperandrogenism (Phase 4)

Hypogonadism ()

Menstruation Disturbances (Phase 4)

Osteoarthritis, Knee (Phase 4)

Pedophilia (Phase 3)

Perimenopause (Phase 2/Phase 3)

Polycystic Ovary Syndrome (Phase 4)

Progesterone (Phase 2/Phase 3)

Prostatic Neoplasms (Phase 3)

Transsexualism (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 31
  • # of Trial Organizations: 58

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue